A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
Clinical trial NCT05987449 · RECRUITING
Trial details
- NCT number
- NCT05987449
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-21
- Primary completion
- 2033-12-11
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.